Emergent BioSolutions to Release Third Quarter 2021 Financial Results and Conduct a Conference Call on November 4, 2021
18 October 2021 - 9:30PM
Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call
on Thursday, November 4, 2021 at 5:00 pm eastern time to discuss
the financial results for the third quarter of 2021, recent
business developments, and financial outlook for full year 2021.
This conference call can be accessed live by telephone or by
webcast:
eleconference
Information:Dial in number – toll-free:
(855) 766-6521Dial in number – toll: (262)
912-6157Conference ID: 2937668
Webcast
Information:Visit
https://edge.media-server.com/mmc/p/nitqgk48 for the live
webcast.
A replay of the call can be accessed from the Emergent
website.
Investor Contact:About Emergent
BioSolutionsEmergent BioSolutions is a global life
sciences company whose mission is to protect and enhance life.
Through our specialty products and contract development and
manufacturing services, we are dedicated to providing solutions
that address public health threats. Through social responsibility,
we aim to build healthier and safer communities. We aspire to
deliver peace of mind to our patients and customers so they can
focus on what’s most important in their lives. In working together,
we envision protecting or enhancing 1 billion lives by 2030. For
more information, visit our website and follow us on LinkedIn,
Twitter, and Instagram.
Robert G. BurrowsVice President, Investor
Relationsburrowsr@ebsi.com
Media Contact:Matt HartwigSenior
Director, Media Relationshartwigm@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2024 to May 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From May 2023 to May 2024